
  <style>
  .gh-table table { 
    border-collapse: collapse; 
    width: 100%;
    border: 1px solid #444;
    font-size: 12px;
  }
  .gh-table th, .gh-table td { 
    border: 1px solid #444; 
    padding: 4px 6px; 
    vertical-align: top;
    font-weight: 400 !important;   /* regular font */
  }
  .gh-table th { 
    .gh-table th { background: #f5f5f5; text-align: left; }
  }
  .gh-table th { font-weight: 700 !important; }
    @media print {
      .gh-table { font-size: 10px; }
    }
  </style>
  <div class='gh-table'><table><thead><tr><th>record_id</th><th>visit</th><th>Molecola (1)</th><th>Molecola (2)</th><th>description</th></tr></thead><tbody><tr><td>L52</td><td>1</td><td>Abacavir</td><td>Bisoprolol</td><td>Bisoprolol may decrease the excretion rate of Abacavir which could result in a
higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Abacavir</td><td>Furosemide</td><td>Furosemide may decrease the excretion rate of Abacavir which could result in a
higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Abacavir</td><td>Lorazepam</td><td>Lorazepam may decrease the excretion rate of Abacavir which could result in a
higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Abacavir</td><td>Pantoprazole</td><td>Pantoprazole may decrease the excretion rate of Abacavir which could result in a
higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Abacavir</td><td>Potassium chloride</td><td>Potassium chloride may decrease the excretion rate of Abacavir which could
result in a higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Beclomethasone dipropionate</td><td>Cholecalciferol</td><td>The therapeutic efficacy of Cholecalciferol can be decreased when used in
combination with Beclomethasone dipropionate.</td></tr><tr><td>L52</td><td>1</td><td>Bisoprolol</td><td>Lorazepam</td><td>Lorazepam may decrease the excretion rate of Bisoprolol which could result in a
higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Bisoprolol</td><td>Pantoprazole</td><td>Pantoprazole may decrease the excretion rate of Bisoprolol which could result in
a higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Dolutegravir</td><td>Beclomethasone dipropionate</td><td>Beclomethasone dipropionate may decrease the excretion rate of Dolutegravir
which could result in a higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Dolutegravir</td><td>Bisoprolol</td><td>The serum concentration of Dolutegravir can be increased when it is combined
with Bisoprolol.</td></tr><tr><td>L52</td><td>1</td><td>Dolutegravir</td><td>Pantoprazole</td><td>Pantoprazole may decrease the excretion rate of Dolutegravir which could result
in a higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Dolutegravir</td><td>Rosuvastatin</td><td>The excretion of Rosuvastatin can be decreased when combined with Dolutegravir.</td></tr><tr><td>L52</td><td>1</td><td>Esomeprazole</td><td>Pantoprazole</td><td>The metabolism of Esomeprazole can be decreased when combined with Pantoprazole.</td></tr><tr><td>L52</td><td>1</td><td>Formoterol</td><td>Bisoprolol</td><td>The therapeutic efficacy of Formoterol can be decreased when used in combination
with Bisoprolol.</td></tr><tr><td>L52</td><td>1</td><td>Formoterol</td><td>Cholecalciferol</td><td>The metabolism of Formoterol can be decreased when combined with
Cholecalciferol.</td></tr><tr><td>L52</td><td>1</td><td>Formoterol</td><td>Esomeprazole</td><td>The metabolism of Formoterol can be decreased when combined with Esomeprazole.</td></tr><tr><td>L52</td><td>1</td><td>Formoterol</td><td>Furosemide</td><td>The risk or severity of hypokalemia can be increased when Formoterol is combined
with Furosemide.</td></tr><tr><td>L52</td><td>1</td><td>Formoterol</td><td>Lamivudine</td><td>The risk or severity of adverse effects can be increased when Formoterol is
combined with Lamivudine.</td></tr><tr><td>L52</td><td>1</td><td>Formoterol</td><td>Pantoprazole</td><td>The metabolism of Formoterol can be decreased when combined with Pantoprazole.</td></tr><tr><td>L52</td><td>1</td><td>Furosemide</td><td>Beclomethasone dipropionate</td><td>The therapeutic efficacy of Furosemide can be increased when used in combination
with Beclomethasone dipropionate.</td></tr><tr><td>L52</td><td>1</td><td>Furosemide</td><td>Bisoprolol</td><td>Bisoprolol may increase the hypotensive activities of Furosemide.</td></tr><tr><td>L52</td><td>1</td><td>Furosemide</td><td>Lorazepam</td><td>Furosemide may decrease the excretion rate of Lorazepam which could result in a
higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Furosemide</td><td>Pantoprazole</td><td>Furosemide may decrease the excretion rate of Pantoprazole which could result in
a higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Glycopyrronium</td><td>Potassium chloride</td><td>The risk or severity of adverse effects can be increased when Glycopyrronium is
combined with Potassium chloride.</td></tr><tr><td>L52</td><td>1</td><td>Lamivudine</td><td>Beclomethasone dipropionate</td><td>Beclomethasone dipropionate may decrease the excretion rate of Lamivudine which
could result in a higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Lamivudine</td><td>Bisoprolol</td><td>Bisoprolol may decrease the excretion rate of Lamivudine which could result in a
higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Lamivudine</td><td>Furosemide</td><td>Furosemide may decrease the excretion rate of Lamivudine which could result in a
higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Lamivudine</td><td>Lorazepam</td><td>Lorazepam may decrease the excretion rate of Lamivudine which could result in a
higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Lamivudine</td><td>Pantoprazole</td><td>Pantoprazole may decrease the excretion rate of Lamivudine which could result in
a higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Pantoprazole</td><td>Lorazepam</td><td>Lorazepam may decrease the excretion rate of Pantoprazole which could result in
a higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Potassium chloride</td><td>Bisoprolol</td><td>Potassium chloride may increase the hyperkalemic activities of Bisoprolol.</td></tr><tr><td>L52</td><td>1</td><td>Potassium chloride</td><td>Furosemide</td><td>Furosemide may decrease the excretion rate of Potassium chloride which could
result in a higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Potassium chloride</td><td>Lamivudine</td><td>Lamivudine may decrease the excretion rate of Potassium chloride which could
result in a higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Potassium chloride</td><td>Lorazepam</td><td>Lorazepam may decrease the excretion rate of Potassium chloride which could
result in a higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Potassium chloride</td><td>Pantoprazole</td><td>Pantoprazole may decrease the excretion rate of Potassium chloride which could
result in a higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Rosuvastatin</td><td>Beclomethasone dipropionate</td><td>Beclomethasone dipropionate may decrease the excretion rate of Rosuvastatin
which could result in a higher serum level.</td></tr><tr><td>L52</td><td>1</td><td>Rosuvastatin</td><td>Esomeprazole</td><td>The excretion of Rosuvastatin can be decreased when combined with Esomeprazole.</td></tr><tr><td>L52</td><td>1</td><td>Rosuvastatin</td><td>Formoterol</td><td>The metabolism of Rosuvastatin can be decreased when combined with Formoterol.</td></tr><tr><td>L52</td><td>1</td><td>Rosuvastatin</td><td>Furosemide</td><td>The excretion of Rosuvastatin can be decreased when combined with Furosemide.</td></tr><tr><td>L52</td><td>1</td><td>Rosuvastatin</td><td>Lamivudine</td><td>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be
increased when Lamivudine is combined with Rosuvastatin.</td></tr><tr><td>L52</td><td>1</td><td>Rosuvastatin</td><td>Pantoprazole</td><td>The excretion of Rosuvastatin can be decreased when combined with Pantoprazole.</td></tr></tbody></table></div>
